Cellular receptors are proteins that bind signaling molecules and initiate intracellular responses. They are classified into four main types based on their structure, location, and mechanism of action.
Ion Channel-Coupled Receptors
Ion channel-coupled receptors, also called ionotropic receptors, are transmembrane proteins that combine receptor and ion channel functions in a single molecule. Binding of the neurotransmitter causes a conformational change that opens or closes the channel, allowing specific ions to flow across the membrane. The response is extremely rapid, occurring in milliseconds.
Nicotinic acetylcholine receptors at the neuromuscular junction open in response to acetylcholine, allowing sodium influx that depolarizes the muscle cell. GABA-A receptors open chloride channels, causing hyperpolarization and neuronal inhibition. Glutamate receptors such as AMPA and NMDA receptors mediate fast excitatory neurotransmission. Ion channel receptors are targets for many drugs, including benzodiazepines that enhance GABA-A receptor activity.
G Protein-Coupled Receptors
GPCRs are the largest family of cell surface receptors, with over 800 members in humans. They share a common structure of seven transmembrane alpha helices connected by alternating intracellular and extracellular loops. The extracellular regions contain the ligand-binding domain, while the intracellular regions couple to heterotrimeric G proteins.
Ligand binding induces a conformational change that activates the associated G protein, which exchanges GDP for GTP on the alpha subunit. The activated G protein dissociates into GTP-bound alpha subunit and the beta-gamma complex, each of which can regulate downstream effector proteins such as adenylyl cyclase, phospholipase C, or ion channels. The response is rapid, occurring within seconds to minutes.
GPCRs mediate responses to diverse stimuli including light, odorants, neurotransmitters, hormones, and chemokines. Approximately one-third of all prescription drugs target GPCRs. Beta-blockers antagonize beta-adrenergic receptors, antihistamines block histamine receptors, and opioid analgesics activate opioid receptors.
Enzyme-Linked Receptors
Enzyme-linked receptors are transmembrane proteins with an extracellular ligand-binding domain and an intracellular domain that either has intrinsic enzyme activity or directly associates with an enzyme. Receptor tyrosine kinases are the largest class. Ligand binding typically induces dimerization, which activates the tyrosine kinase domain and leads to autophosphorylation of specific tyrosine residues. These phosphotyrosines serve as docking sites for downstream signaling proteins containing SH2 or PTB domains.
The insulin receptor is a preformed dimer that undergoes conformational change upon insulin binding. The epidermal growth factor receptor dimerizes after ligand binding. Cytokine receptors lack intrinsic kinase activity but associate with cytoplasmic JAK kinases that become activated upon receptor aggregation. Guanylyl cyclase receptors, such as the atrial natriuretic peptide receptor, synthesize cGMP directly. Serine-threonine kinase receptors, such as TGF-beta receptors, phosphorylate SMAD transcription factors.
Nuclear Receptors
Nuclear receptors are ligand-activated transcription factors that reside in the cytoplasm or nucleus. They share a conserved domain structure: an N-terminal activation domain, a DNA-binding domain with two zinc fingers, a flexible hinge region, and a C-terminal ligand-binding domain. Steroid hormone receptors such as the glucocorticoid receptor reside in the cytoplasm bound to heat shock proteins. Hormone binding releases the chaperones and exposes a nuclear localization signal, allowing translocation to the nucleus.
In the nucleus, the receptor binds as a dimer to specific DNA sequences called hormone response elements. Coactivator or corepressor proteins are recruited to regulate transcription. The response is slow relative to membrane receptors, requiring gene transcription and protein synthesis over hours to days. However, some nuclear receptors can also mediate rapid non-genomic effects through membrane-associated receptors.
Receptor Regulation
Receptor activity is tightly regulated to prevent overstimulation. Desensitization reduces receptor responsiveness during continuous agonist exposure. GPCR kinases phosphorylate activated GPCRs, promoting arrestin binding that uncouples the receptor from G proteins and targets it for internalization. Internalized receptors can be dephosphorylated and recycled to the membrane or degraded in lysosomes. Downregulation reduces total receptor number through decreased synthesis or increased degradation. These regulatory mechanisms contribute to drug tolerance and the phenomenon of tachyphylaxis.
